Clinical Trials Logo

Clinical Trial Summary

Aims of this study is to characterize the pharmacokinetic/pharmacodynamic profile and evaluate the safety, efficacy and tolerability, of tamsulosin hydrochloride as treatment in children with a neuropathic bladder, over the course of 12 months of active treatment.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00340704
Study type Interventional
Source Boehringer Ingelheim
Contact
Status Completed
Phase Phase 2
Start date April 2006
Completion date June 2009

See also
  Status Clinical Trial Phase
Completed NCT03593512 - Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy N/A
Not yet recruiting NCT03698721 - Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate
Active, not recruiting NCT00175123 - Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele Phase 4
Recruiting NCT04738539 - Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies
Completed NCT00591240 - A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection N/A
Completed NCT03908047 - Functional Changes in the Brain After Tibial Nerve Stimulation: a Pilot Study
Recruiting NCT06337942 - Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study N/A
Completed NCT00796614 - Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder Phase 2/Phase 3